tagrisso
astrazeneca ab - osimertinib mesilate - carcinoma, pulmón no microcítico - otros agentes antineoplásicos, inhibidores de la proteína quinasa - tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations- the first-line treatment of adult patients nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc. tagrisso as monotherapy is indicated for:- the adjuvant treatment after complete tumour resection in adult patients with stage ib-iiia non-small cell lung cancer (nsclc) whose tumours have epidermal growth factor receptor (egfr) exon 19 deletions or exon 21 (l858r) substitution mutations. - the first-line treatment of adult patients with locally advanced or metastatic nsclc with activating egfr mutations. - the treatment of adult patients with locally advanced or metastatic egfr t790m mutation-positive nsclc.
mutagrip suspension inyectable en jeringa precargada
sanofi pasteur europe - virus gripe a h3n2 inactivado fraccionado, virus gripe a h1n1 inactivado fraccionado, virus gripe b inactivado - suspensiÓn inyectable en jeringa precargada - n/a (vacuna) - n/a (vacuna) n/a (vacuna) - influenza, antígeno purificado
liquifilm lagrimas 14 mg/ml colirio en solucion
allergan s.a. - polivinilico alcohol - colirio en soluciÓn - 14 mg/ml - polivinilico alcohol 14 mg - lágrimas artificiales y otros preparados inertes
lagrimas isotonicas 1.4% solucion oftalmica
laboratorios lansier s.a.c. - droguerÍa - alcohol polivinilico; - solucion oftalmica - por mililitro - - lágrimas artificiales y otros preparados inertes
lagrimas naturales 1mg+3mg solucion oftalmica
alcon pharmaceutical del peru s.a. - droguerÍa - dextran; hidroxipropilmetilcelulosa; - solucion oftalmica - por dosis - - lágrimas artificiales y otros preparados inertes
mutagrip 1 jeringa precargada 0,5 ml
tagrisso 40 mg 30 comprimits recoberts
tagrisso 80 mg 30 comprimits recoberts
tagrisso 80 mg
astrazeneca ab, sÖdertÄlje, suecia - osimertinib - comprimido recubierto - 80 mg
tagrisso 40 mg
astrazeneca ab, sÖdertÄlje, suecia - osimertinib - comprimido recubierto - 40 mg